Transplanting Mesenchymal Stem Cells for Treatment of Ischemic Stroke

Overview

Journal Cell Transplant

Specialties Cell Biology
General Surgery

Date 2018 Sep 26

PMID 30251564

Citations 52

Authors

Fan Wang

Hailiang Tang

Jianhong Zhu

John H Zhang

Affiliations

Soon will be listed here.

Abstract

Stroke is a major disease that leads to high mortality and morbidity. Given the ageing population and the potential risk factors, the prevalence of stroke and socioeconomic burden associated with stroke are expected to increase. During the past decade, both prophylactic and therapeutic strategies for stroke have made significant progress. However, current therapies still cannot adequately improve the outcomes of stroke and may not apply to all patients. One of the significant advances in modern medicine is cell-derived neurovascular regeneration and neuronal repair. Progress in stem cell biology has greatly contributed to ameliorating stroke-related brain injuries in preclinical studies and demonstrated clinical potential in stroke treatment. Mesenchymal stem cells (MSCs) have the differentiating potential of chondrocytes, adipocytes, and osteoblasts, and they have the ability to transdifferentiate into endothelial cells, glial cells, and neurons. Due to their great plasticity, MSCs have drawn much attention from the scientific community. This review will focus on MSCs, stem cells widely utilized in current medical research, and evaluate their effect and potential of improving outcomes in ischemic stroke.

Citing Articles

Mesenchymal stem cells and their extracellular vesicle therapy for neurological disorders: traumatic brain injury and beyond.

Yarahmadi A, Dorri Giv M, Hosseininejad R, Rezaie A, Mohammadi N, Afkhami H Front Neurol. 2025; 16:1472679.

PMID: 39974358 PMC: 11835705. DOI: 10.3389/fneur.2025.1472679.

Mesenchymal stem cells lineage and their role in disease development.

Xu Q, Hou W, Zhao B, Fan P, Wang S, Wang L Mol Med. 2024; 30(1):207.

PMID: 39523306 PMC: 11552129. DOI: 10.1186/s10020-024-00967-9.

Human neural stem cells derived from fetal human brain communicate with each other and rescue ischemic neuronal cells through tunneling nanotubes.

Capobianco D, De Zio R, Profico D, Gelati M, Simone L, DErchia A Cell Death Dis. 2024; 15(8):639.

PMID: 39217148 PMC: 11365985. DOI: 10.1038/s41419-024-07005-w.

Efficacy and safety of mesenchymal stem cell therapies for ischemic stroke: a systematic review and meta-analysis.

Shen Z, Tang X, Zhang Y, Jia Y, Guo X, Guo X Stem Cells Transl Med. 2024; 13(9):886-897.

PMID: 39159204 PMC: 11386217. DOI: 10.1093/stcltm/szae040.

Stem cell therapy as a promising approach for ischemic stroke treatment.

Yaqubi S, Karimian M Curr Res Pharmacol Drug Discov. 2024; 6:100183.

PMID: 38831867 PMC: 11144755. DOI: 10.1016/j.crphar.2024.100183.

References

Toma C, Pittenger M, Cahill K, Byrne B, Kessler P . Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation. 2002; 105(1):93-8. DOI: 10.1161/hc0102.101442. View

Xin H, Li Y, Cui Y, Yang J, Zhang Z, Chopp M . Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J Cereb Blood Flow Metab. 2013; 33(11):1711-5. PMC: 3824189. DOI: 10.1038/jcbfm.2013.152. View

Baghaei K, Hashemi S, Tokhanbigli S, Asadi Rad A, Assadzadeh-Aghdaei H, Sharifian A . Isolation, differentiation, and characterization of mesenchymal stem cells from human bone marrow. Gastroenterol Hepatol Bed Bench. 2017; 10(3):208-213. PMC: 5660271. View

Garcia-Bonilla L, Benakis C, Moore J, Iadecola C, Anrather J . Immune mechanisms in cerebral ischemic tolerance. Front Neurosci. 2014; 8:44. PMC: 3940969. DOI: 10.3389/fnins.2014.00044. View

Boltze J, Ayata C . Challenges and Controversies in Translational Stroke Research - an Introduction. Transl Stroke Res. 2016; 7(5):355-7. DOI: 10.1007/s12975-016-0492-4. View

Krishnamurthi R, Feigin V, Forouzanfar M, Mensah G, Connor M, Bennett D . Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet Glob Health. 2014; 1(5):e259-81. PMC: 4181351. DOI: 10.1016/S2214-109X(13)70089-5. View

Pittenger M, Mackay A, Beck S, Jaiswal R, Douglas R, Mosca J . Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284(5411):143-7. DOI: 10.1126/science.284.5411.143. View

Islam M, Das S, Emin M, Wei M, Sun L, Westphalen K . Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat Med. 2012; 18(5):759-65. PMC: 3727429. DOI: 10.1038/nm.2736. View

Chen J, Crawford R, Chen C, Xiao Y . The key regulatory roles of the PI3K/Akt signaling pathway in the functionalities of mesenchymal stem cells and applications in tissue regeneration. Tissue Eng Part B Rev. 2013; 19(6):516-28. DOI: 10.1089/ten.TEB.2012.0672. View

10.

Bronckaers A, Hilkens P, Martens W, Gervois P, Ratajczak J, Struys T . Mesenchymal stem/stromal cells as a pharmacological and therapeutic approach to accelerate angiogenesis. Pharmacol Ther. 2014; 143(2):181-96. DOI: 10.1016/j.pharmthera.2014.02.013. View

11.

Koga K, Matsumoto K, Akiyoshi T, Kubo M, Yamanaka N, Tasaki A . Purification, characterization and biological significance of tumor-derived exosomes. Anticancer Res. 2005; 25(6A):3703-7. View

12.

Li H, Fan X, Kovi R, Jo Y, Moquin B, Konz R . Spontaneous expression of embryonic factors and p53 point mutations in aged mesenchymal stem cells: a model of age-related tumorigenesis in mice. Cancer Res. 2007; 67(22):10889-98. DOI: 10.1158/0008-5472.CAN-07-2665. View

13.

Erices A, Conget P, Minguell J . Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol. 2000; 109(1):235-42. DOI: 10.1046/j.1365-2141.2000.01986.x. View

14.

Hsuan Y, Lin C, Chang C, Lin M . Mesenchymal stem cell-based treatments for stroke, neural trauma, and heat stroke. Brain Behav. 2016; 6(10):e00526. PMC: 5064338. DOI: 10.1002/brb3.526. View

15.

Lv F, Tuan R, Cheung K, Leung V . Concise review: the surface markers and identity of human mesenchymal stem cells. Stem Cells. 2014; 32(6):1408-19. DOI: 10.1002/stem.1681. View

16.

Yavagal D, Lin B, Raval A, Garza P, Dong C, Zhao W . Efficacy and dose-dependent safety of intra-arterial delivery of mesenchymal stem cells in a rodent stroke model. PLoS One. 2014; 9(5):e93735. PMC: 4012944. DOI: 10.1371/journal.pone.0093735. View

17.

Tsai M, Tsai S, Hu B, Liou D, Huang S, Huang M . Recovery of neurological function of ischemic stroke by application of conditioned medium of bone marrow mesenchymal stem cells derived from normal and cerebral ischemia rats. J Biomed Sci. 2014; 21:5. PMC: 3922747. DOI: 10.1186/1423-0127-21-5. View

18.

Bang O, Lee J, Lee P, Lee G . Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol. 2005; 57(6):874-82. DOI: 10.1002/ana.20501. View

19.

Ge J, Guo L, Wang S, Zhang Y, Cai T, Zhao R . The size of mesenchymal stem cells is a significant cause of vascular obstructions and stroke. Stem Cell Rev Rep. 2014; 10(2):295-303. DOI: 10.1007/s12015-013-9492-x. View

20.

Gu N, Rao C, Tian Y, Di Z, Liu Z, Chang M . Anti-inflammatory and antiapoptotic effects of mesenchymal stem cells transplantation in rat brain with cerebral ischemia. J Stroke Cerebrovasc Dis. 2014; 23(10):2598-2606. DOI: 10.1016/j.jstrokecerebrovasdis.2014.05.032. View